Clarence Ahlem's Insider Trades & SAST Disclosures

Clarence Ahlem's most recent trade in BioVie Inc was a trade of 2,476 COMMON STOCK done at an average price of $6.1 . Disclosure was reported to the exchange on Feb. 16, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
BioVie Inc
Clarence Ahlem EVP Neuroscience Product Dev. Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.12 per share. 16 Feb 2023 2,476 37,148 (0%) 0% 6.1 15,153 COMMON STOCK
BioVie Inc
Clarence Ahlem EVP Neuroscience Product Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Nov 2022 39,624 39,624 (0%) 0% 0 COMMON STOCK
BioVie Inc
Clarence Ahlem EVP Neuroscience Product Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Aug 2021 124,167 124,167 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades